Krishna Institute of Medical Sciences Share Price

NSE
679.5
+18.20 (2.69%)
KIMS • 13 Jun, 2025 | 03:29 PM
BUY

1Y Annualised Return

64.79%

3Y Annualised Return

40.07%

The current prices are delayed, login or Open Demat Account for live prices.

Krishna Institute of Medical Sciences SIP Return Calculator

Over the past

1 year
3 years

Total Investment of ₹65,00,000

Would have become ₹91,52,069 (+40.80%)

Daily SIP of 25,000 would have become 91,52,069 in 1 year with a gain of 26,52,069 (+40.80%)

Krishna Institute of Medical Sciences Stock Performance
Today’s Low - High
645.10
684.85
645.10
684.85
52 Week Low - High
394.09
708.00
394.09
708.00

Open

645.10

Prev. Close

661.30

Total Traded Value

54.41 Cr

View details of Market Depth
Krishna Institute of Medical Sciences Fundamental

Market Cap (in crs)

27,207.45

Face Value

2

Turnover (in lacs)

5,441.40

Key Metrics
Qtr Change %
Near 52W High of ₹708.00
19.2
Dividend yield 1yr %
0

Krishna Institute of Medical Sciences Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Krishna Institute of Medical Sciences Quarterly Revenue

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
796.9 Cr
772.4 Cr
777.3 Cr
688.4 Cr
633.8 Cr

Krishna Institute of Medical Sciences Yearly Revenue

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
3067 Cr
2511.2 Cr
2223.55 Cr
1671.08 Cr
1340.1 Cr
1128.73 Cr

Krishna Institute of Medical Sciences Quarterly Net Profit/Loss

Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
106.1 Cr
92.5 Cr
120.7 Cr
95.2 Cr
71.62 Cr

Krishna Institute of Medical Sciences Yearly Net Profit/Loss

Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
414.8 Cr
336.28 Cr
365.81 Cr
334.28 Cr
205.48 Cr
115.07 Cr
Krishna Institute of Medical Sciences Result Highlights
  • Krishna Institute of Medical Sciences Ltd reported a 19.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a growth of 9.8%.

  • Its expenses for the quarter were down by 18.0% QoQ and up 18.5% YoY.

  • The net profit decreased 22.7% QoQ and decreased 27.5% YoY.

  • The earnings per share (EPS) of Krishna Institute of Medical Sciences Ltd stood at 8.2 during Q4FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Krishna Institute of Medical Sciences shareholding Pattern

Promoter
38.8%
Foreign Institutions
15.4%
Mutual Funds
25.4%
Domestic Institutions
32%
Public
13.8%
Promoter
38.8%
Foreign Institutions
15.7%
Mutual Funds
26%
Domestic Institutions
32%
Public
13.4%
Promoter
38.8%
Foreign Institutions
15.8%
Mutual Funds
25.8%
Domestic Institutions
32.3%
Public
13%
Promoter
38.8%
Foreign Institutions
17.8%
Mutual Funds
25.3%
Domestic Institutions
32.2%
Public
11.2%
Promoter
38.8%
Foreign Institutions
16.7%
Mutual Funds
26.3%
Domestic Institutions
33.2%
Public
11.3%
Promoter
38.8%
Foreign Institutions
15.3%
Mutual Funds
27.4%
Domestic Institutions
34.2%
Public
11.7%

Krishna Institute of Medical Sciences Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
679.5
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
667.70
10Day EMA
664.70
12Day EMA
664.00
20Day EMA
661.20
26Day EMA
658.70
50Day EMA
646.60
100Day EMA
624.50
200Day EMA
584.50
5Day SMA
663.60
10Day SMA
664.10
20Day SMA
662.00
30Day SMA
657.10
50Day SMA
649.50
100Day SMA
616.70
150Day SMA
610.60
200Day SMA
592.00
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
485427 Rs
897685 Rs
Week Rs
299599 Rs
544794 Rs
Month Rs
273518 Rs
537319 Rs
Resistance & Support
669.97
Pivot
Resistance
First Resistance
694.83
Second Resistance
709.72
Third Resistance
734.58
Support
First Support
655.08
Second support
630.22
Third Support
615.33
Relative Strength Index
57.38
Money Flow Index
56.02
MACD
5.32
MACD Signal
5.36
Average True Range
24.15
Average Directional Index
9.42
Rate of Change (21)
5.62
Rate of Change (125)
11.19
Shareholding
Name
Holding Percent
SBI Small Cap Fund
6.31
Axis Mutual Fund Trustee Limited A/C Axis Mutual Fund A/C Axis Small Cap Fund
5.17
Hdfc Small Cap Fund
4.49
Kotak Small Cap Fund
3.07
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund
1.67
Amansa Holdings Private Limited
1.93
Nomura India Investment Fund Mother Fund
1.72
Sbi Life Insurance Co. Ltd
3.52
Tata Aia Life Insurance Co Ltd-Whole Life Mid Cap Equity Fund-Ulif 009 04/01/07 Wle 110
1.4
Hdfc Life Insurance Company Limited
1.19

Krishna Institute of Medical Sciences Latest News

09 JUN 2025 | Monday

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

05 JUN 2025 | Thursday

Krishna Institute of Medical Sciences Ltd - 543308 - Allotment Of Equity Shares By KIMS Hospital Bengaluru Private Limited, A Wholly-Owned Subsidiary Of The Company On Preferential Basis.

13 MAY 2025 | Tuesday

Krishna Institute of Medical Sciences Ltd - 543308 - Announcement under Regulation 30 (LODR)-Newspaper Publication

View More

Krishna Institute of Medical Sciences Company background

Founded in: 1973
Managing director: Bhaskara Rao Bollineni
Krishna Institute of Medical Sciences Limited (KIMS) was erstwhile incorporated as Jagjit Singh and Sons Private Limited, a Private Limited Company on July 26, 1973 in Mumbai. Subsequently, the name of the Company changed to Krishna Institute of Medical Sciences Private Limited on January 2, 2004 and further upon its conversion to a Public Limited Company, the name was changed to Krishna Institute of Medical Sciences Limited on January 29, 2004. The Company is one of the largest corporate groups in India, with hospitals in Telangana, Andhra Pradesh Maharashtra providing multidisciplinary integrated services with a focus on tertiary and quaternary healthcare at affordable cost. It is engaged in rendering medical and healthcare services. It operate 12 multispecialty hospitals under the KIMS Hospitals brand, with an aggregate capacity of over 4,000 beds. It offer a comprehensive range of healthcare services in over 40 specialties and super specialties, including cardiac sciences, oncology, neurosciences, gastric sciences, orthopaedics, organ transplantation, renal sciences and mother child care.Until the year 2003, the Company was owned, managed and controlled by Jagjit Singh and certain of his family members, who together owned the entire shareholding of the Company. In February 2003, acting in pursuance of the Takeover MoU, certain of its Promoters, namely Dr. Bhaskar Rao Bollineni, Krishnaiah Bollineni and BRMH, along with certain other individuals and entities, acquired the entire equity share capital of the Company.Led by Dr. Bhaskar Rao Bollineni, Managing Director and CEO of the Company, a renowned cardiothoracic surgeon, it has grown from a single hospital to a chain of multispecialty hospitals, both organically and through strategic acquisitions. The oldest hospital in their network was established in 2000 at Nellore, by its Corporate Promoter, BRMH, with a capacity of approximately 200 beds and, At present, the hospital network has grown to six multispecialty hospitals in six cities, with a total capacity of 4000 beds, including 1,705 operational beds. The Hospitals are equipped with stateoftheart medical equipment and employ practices and policies which help to provide quality healthcare services to their patients. It was one of the first hospitals in Hyderabad to install 4Arm HD da Vinci Robot technology at Secunderabad hospital. The flagship hospitals at Secunderabad and Rajahmundry have been accredited by the National Accreditation Board for Hospitals and Healthcare Providers, India (NABH). The Hospital at Secunderabad is accredited with ISO 9001:2008 certification and has also been accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The Hospital situated at Secunderabad was awarded the Healthcare Excellence Award, by the Indo Global Healthcare Summit and Expo, in 2015. It has also received awards from the Association of Healthcare Providers (India) (AHPI) for nursing excellence, in 2015 and for Patient Friendly Hospital, in 2017. In 2017, it was awarded the best hospital of the year in the multispecialty hospital category in Hyderabad by Times Healthcare Achievers Awards and in 2016 received the Pharmacie DeQualite certification from Bureau Veritas. Further, it was the first hospital in Andhra Pradesh and Telangana to have been Green OT certified in 2016. It is also the laureate of the Asia Pacific Society of Infection Control CSSD Center of Excellence Silver Award 20152016. Neurology India Journal has ranked the neurology department at its hospital at Secunderabad as the third biggest centre in India on the basis of volume of epilepsy surgeries performed, as on July 31, 2016.In addition to healthcare services, the company also conduct medical education programmes through its affiliations with state medical boards and universities, for various broad and super specialties at its hospitals in Secunderabad and Rajahmundry, including for DNB, under graduation, postgraduation, PhD and diploma programmes. It is also affiliated with Kaloji Narayana Rao University of Health Sciences and the Andhra Pradesh Para Medical Board.During 2022, Sunshine Hospitals became subsidiary of the Company effective from April, 2022. In 202223, the Company opened an exclusive Gastroenterology unit at Vizag. During FY 202223, Sarvejana Healthcare Private Limited became a Subsidiary of the Company effective 01st April 2022 SPANV Medisearch Lifesciences Private Limited became the Subsidiary of Company on 01.09.2022. Suryateja Healthcare Private Limited has ceased to be step down subsidiary of the Company w.e.f. December 01, 2022.The Nagpur Hospital became functional in 2024. The Company acquired a running hospital of 200 bedsQUEENS NRI HOSPITAL in Vizag, Andhra Pradesh in Jul24.

As of 13 Jun, 2025, KIMS share price is ₹680. The stock opened at ₹645.1 and had closed at ₹661.3 the previous day. During today’s trading session, KIMS share price moved between ₹645.10 and ₹684.85, with an average price for the day of ₹664.50. Over the last 52 weeks, the stock has recorded a low of ₹394.09 and a high of ₹708.00. In terms of performance, KIMS share price has increased by 14.8% over the past six months and has increased by 64.79% over the last year.

Read More

Krishna Institute of Medical Sciences FAQs

Krishna Institute of Medical Sciences share price is ₹679.5 in NSE and ₹678.65 in BSE as on 13/6/2025.

Krishna Institute of Medical Sciences share price in the past 1-year return was 69.43. The Krishna Institute of Medical Sciences share hit a 1-year low of Rs. 394.09 and a 1-year high of Rs. 708.

The market cap of Krishna Institute of Medical Sciences is Rs. 27207.45 Cr. as of 13/6/2025.

The PE ratios of Krishna Institute of Medical Sciences is 92.23 as of 13/6/2025.

The PB ratios of Krishna Institute of Medical Sciences is 12.54 as of 13/6/2025

The Mutual Fund Shareholding in Krishna Institute of Medical Sciences was 25.35% at the end of 13/6/2025.

You can easily buy Krishna Institute of Medical Sciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Please be aware that Krishna Institute of Medical Sciences stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account
+91 -

Open Demat Account
+91 -